Palmer Christopher M
Metabolic and Mental Health Program, McLean Hospital, Belmont, MA, USA.
Psychiatry, Harvard Medical School, Boston, MA, USA.
BJPsych Open. 2025 May 9;11(3):e94. doi: 10.1192/bjo.2025.50.
The ketogenic diet, initially developed for epilepsy treatment, has gained attention as a potential intervention for neuropsychiatric disorders. A groundbreaking study by Campbell et al highlights its feasibility and potential efficacy in bipolar disorder, shedding light on shared mechanisms across neuropsychiatric disorders and the promise of metabolic treatment approaches.
生酮饮食最初是为治疗癫痫而开发的,如今作为一种针对神经精神疾病的潜在干预措施受到了关注。坎贝尔等人的一项开创性研究强调了其在双相情感障碍中的可行性和潜在疗效,揭示了神经精神疾病之间的共同机制以及代谢治疗方法的前景。